Target intelligence / Profile preview

Neuroblastoma breakpoint family member 20 (NBPF20)

Target
NBPF20
Molecular classification
Other (member of the NBPF gene family; not a receptor, enzyme, transporter, ion channel, or classical transcription factor)
01

Overview

Neuroblastoma breakpoint family member 20 (NBPF20) is a protein-coding gene located on human chromosome 1q21.1 and part of the NBPF gene family, which is notable for primate-lineage-specific expansions and high copy number variation[1][3][6]. NBPF genes are characterized by multiple tandem DUF1220 protein domains, and copy number variations in this region are linked to various neurodevelopmental disorders and certain cancers, including neuroblastoma[3][4][6]. While altered expression and copy number have pathogenic significance, especially in neurological development and tumorigenesis, the precise molecular functions of NBPF20 remain poorly understood and it is not classified as a canonical therapeutic target such as receptor, enzyme, or transcription factor[3][6][7].\n\nNote: There is no evidence NBPF20 is a direct drug target, established biomarker, or safety concern. Its primary relevance is as a member of a gene family undergoing recent evolutionary expansion, implicated in copy number variation disorders and, indirectly, in cancer and developmental diseases.

Other names
NBPF20Neuroblastoma breakpoint family member 20NBPF family member NBPF20
02

Biological functions

Other (precise molecular function unknown; implicated in neurodevelopment and associated with tandem DUF1220 domain repeats)
03

Disease associations

Cancer (expression or copy number implicated in neuroblastoma, several cancers)Neurodevelopmental disease (duplications/deletions associated with microcephaly, macrocephaly, autism, schizophrenia, cognitive disability)Cardiovascular disease (associated with congenital heart disease)Other (kidney and urinary tract anomalies)

Beyond the preview

Go deeper on Neuroblastoma breakpoint family member 20 (NBPF20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroblastoma breakpoint family member 20 (NBPF20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call